# Procter & Gamble Health Ltd (PGHL)
> Exchange: NSE | Sector: Pharma | ISIN: INE199A01012

## Price
Current Price: ₹5553
Day Change: +1.8%
52W High: ₹6739
52W Low: ₹4707
Market Cap: ₹8,723 Cr

## Valuation
P/E: 36.86
P/B: 14.08
EPS: ₹142.57
Book Value: ₹373.35
Dividend Yield: 0%

## Returns
1Y Return: -11.62%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0.01
Revenue Growth: 20.7%
Profit Growth: -14.6%
EBITDA Margin: 29.24%
Operating Margin: 27.97%

## About
Procter & Gamble Health Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Procter & Gamble Health Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Sale Of Immovable Properties
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- BSE Filing: Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Sale Of Immovable Properties

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:14.480Z
Price History Updated: 2026-05-18T22:58:28.715Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:28.715Z
Quant Updated: 2026-05-18T22:58:28.715Z
Sentiment Updated: 2026-05-18T22:58:28.715Z
Financials Status: current
Financials Updated: 2026-05-18T11:31:06.874Z
Financials Last Attempt: 2026-05-18T11:31:06.874Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹1129.49 Cr
Operating Profit: ₹279.11 Cr (OPM 24.71%)
Net Profit: ₹200.98 Cr
Tax: ₹72.34 Cr

## Annual P&L History
FY25: Rev ₹1129.49Cr | PAT ₹200.98Cr | OPM 24.71%
FY24: Rev ₹1205.86Cr | PAT ₹229.47Cr | OPM 24.53%
FY23: Rev ₹1092.04Cr | PAT ₹192.52Cr | OPM 22.69%

## Balance Sheet (FY25)
Total Assets: ₹794.36 Cr
Total Liabilities: ₹256.12 Cr
Borrowings: ₹9.56 Cr
Cash: ₹238.5 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Milind Vasant Thatte M.B.A., MD & Executive Director
- Zeal Bhavin Rupani, Company Secretary & Compliance Officer
- Shashank  Srowthy, CFO & Executive Director
- Vishal  Naik, Director of Sales, Distributor Operations & Sales Stewardship Leader
- Sanika  Gokhale, Human Resource Leader

---
Source: rupiya.io/stocks/pghl
Disclaimer: For research and education only. Not investment advice.